Zacks.com on MSN2h
Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug
To foray into the lucrative obesity market, Merck MRK announced that it is in-licensing global rights to an investigational ...
Merck: Healthcare Pharma Giant: 3.2% Yield, 9.3% 5-Year Dividend Growth, Buy Time
Merck & Co., a global pharmaceutical leader, focuses on oncology, immunology, and vaccines. Click here to check out my ...
pharmaphorum5h
MSD makes its obesity move with $2bn Hansoh deal
The big pharma is paying Hansoh $112 million upfront to place its bet on oral GLP-1 receptor agonist HS-1035, with another $1 ...
Super Micro Stock Was Hurt by the Fed. Why SMCI Is Rising Now.
The server maker has been on a roller coaster, getting caught up in the excitement about artificial intelligence which helped shares lift to a March high, but worries about accounting dragged them ...
Al Bawaba News8h
Merck comes up with weight loss drug deal worth $2 billion with China
Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named ...
Business Times15h
Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 billion. Read ...
thedailyupside16h
Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker
By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals' dominance in the GLP-1 ...
Merck Joins With Chinese Distributor On Weight Loss Pill
( MENAFN - Baystreet) Merck (NYSE:MRK) on Wednesday said it has snagged the rights to an experimental weight loss pill from ...
What's Going On With Viking Therapeutics Stock On Wednesday?
Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company, entered into an exclusive global license ...
MT Newswires on MSN21h
Merck Strikes Deal With China's Hansoh Pharma to Develop Weight Loss Drug
Merck (MRK) secured exclusive rights to develop and sell an oral weight loss drug under a license deal with Hansoh Pharma that could fetch the Chinese biopharmaceutical company up to $2 billion. Merck ...